Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 14, Issue 2, 2008, Pages 74-77

  Zonana Nacach, Abraham ^a,c   Santana Sahagún, Ernesto ^a   Jiménez Balderas, Francisco Javier ^b   Camargo Coronel, Adolfo ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c NONE   (United States)

Author keywords

Metabolic syndrome; Prevalence; RA; Risk factors; SLE

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; MORBIDITY; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNDERWEIGHT; WAIST CIRCUMFERENCE;

ADULT; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INTERVIEWS AS TOPIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; OBESITY; PAIN MEASUREMENT; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 42049110219     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31816b2faa     Document Type: Article

References (21)

1. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54-58.
2. Bessant R, Hingorani A, Patel L, et al. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford). 2004;43:924-929.
3. Abou Raya A, Abou Raya S. Inflammation a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev. 2006;5:331-337.
4. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005;35:8-17.
5. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States 2000. JAMA. 2004;291:1238-1245.
6. Foucan L, Hanley J, Deloumeaux J, et al. Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol. 2002;55:990-996.
7. Sargeant LA, Bennett FI, Forrester TE, et al. Predicting incident diabetes in Jamaica: the role of anthropometry. Obes Res. 2002;10:792-798.
8. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52:402-411.
9. van Doornum S, Brand C, King B, et al. Increase case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:2061-2068.
10. Karvounaris SA, Sidiropoulos PI, Papadakis JA, et al. Metabolic syndrome is common among middle to older age Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled study. Ann Rheum Dis. 2007;66:28-33.
11. El Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxided low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol. 2006;33:50-56.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Adult Treatment Panel III. JAMA. 2001;285:2486-2497.
15. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res. 2004;35:76-81.
16. Zonana-Nacach A, Castillon-Chapa MA. Frequency of the metabolic syndrome among overweight and obese patients in a primary health care facility in northern Mexico. Gac Med Mex. 2006;142:299-301.
17. Fernald LC, Gutierrez JP, Neufeld LM, et al. High prevalence of obesity among the poor in Mexico. JAMA. 2004;291:2544-2545.
18. Park YB, Choi HK, Kim MY, et al. Effect of antirherumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med. 2002;113:188-193.
19. Choi HK, Seeger JD. Lipid profile among US elderly with untreated rheumatoid arthritis: The third National Heath and Nutrition Examination Survey. J Rheumatol. 2005;32:2311-2316.
20. Dessein PH, Joffe BI, Stanwix A, et al. The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol. 2006;29:462-466.
21. Schneider JG, Finck BN, Ren J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006;4:377-389.